Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients Undergoing Colonoscopy
Effect of Single Dose of 2L PEG on Bowel Preparation in Average-risk Patients
Adequate quality of bowel preparation(BP) is important for colonoscopy. Several guidelines recommend that split-dose of 4L PEG should be used as a standard regime for BP. However, the high-volume PEG still results in lower compliance to the regime and increased cost.
Some high risk factors for inadequate BP have been identified, including old age, constipation, diabetes, the use of narcotics and prior history of inadequate BP. For average-risk patients without the high risk factors, the procedure of BP could be easier. In the previous study, with the use of single dose of 2L PEG, more than 90% of average-risk patients achieved adequate BP. Here investigators hypothesized that compared with the standard split dose of 4L PEG, single dose of 2L PEG may be not inferior in BP quality while may be accompanied with better tolerability.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Qinghai
-
Xining, Qinghai, Kina, 810000
- Department of gastroenterology, Qinghai Provincial People's Hospital
-
-
Shaanxi
-
Xi'an, Shaanxi, Kina, 710032
- Department of gastroenterology, Shaanxi Second People's Hospital
-
-
Shanxi
-
Xi'an, Shanxi, Kina, 710032
- Endoscopic center, Xijing Hospital of Digestive Diseases
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients undergoing colonoscopy;
Patients with average risks for inadequate BP (Patients were identified average-risk if they did not meet any factor of the following risk factors):
- Constipation
- Diabetes
- Parkinson's disease
- History of stroke or spine cord injure
- Prior history of inadequate bowel preparation
- BMI>25
- Use of tricyclic antidepressant or narcotics
Exclusion Criteria:
- History of colorectal resection;
- Suspected colonic stricture or perforation;
- Incomplete or complete bowel obstruction;
- Use of prokinetic agents or purgatives within 7 days;
- Toxic colitis or megacolon;
- Pregnancy or lactation;
- Unable to give informed consent;
- Haemodynamically unstable.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Single dose of 2L PEG
2 L of PEG solution was used on the day of colonoscopy.
|
Patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy.
Patients began to drink 2 L of PEG 4-6 hours before colonoscopy at a rate of 250 mL every 15 minutes.
|
|
Aktiv komparator: Split-dose of 4L PEG
Split-dose of 4l PEG was used before and on the day of colonoscopy
|
All patients at average risk for inadequate BP were given instructions for bowel preparation through phone call a day before scheduled colonoscopy.
the participants began to drink the first 2 L of PEG at 7:00-9:00 PM on the day before colonoscopy at a rate of 250 mL every 15 minutes.
On the day of the procedure, patients took the remaining 2 L 4-6 hours before colonoscopy.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Rate of adequate bowel preparation(defined as a total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2)
Tidsramme: 1 year
|
The adequacy of bowel preparation is defined as Boston Bowel Preparation Scale (BBPS), a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side.
They were summed to give the total BBPS score, which ranged from 0 to 9.The withdrawal procedure was recorded by vedios.
The BBPS and segmental scores in each segment were judged by one endoscopist who was familiar with the criteria of BBPS and blinded to group allocation.
|
1 year
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Uttakstid
Tidsramme: 1 år
|
1 år
|
|
|
Polyp detection rate
Tidsramme: 1 year
|
1 year
|
|
|
Rate of adverse events
Tidsramme: 1 year
|
adverse events, such as vomiting, nausea, headache, abdominal pain
|
1 year
|
|
Cecal intubation rate
Tidsramme: 1 year
|
1 year
|
|
|
Cecal intubation time
Tidsramme: 1 year
|
1 year
|
|
|
Willingness to repeat bowel preparation
Tidsramme: 1 year
|
The number of patients have a willingness to undergo a repeated bowel preparation if needed
|
1 year
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- KY20162097-5
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .